Alzheimer’s Genetic Risk Score linked to Incident Mild Behavioral Impairment
Shea J. AndrewsiD, Zahinoor IsmailiD, Kaarin Jane AnsteyiD, Moyra E. MortbyiD
Abstract
Mild Behavioral Impairment (MBI) describes the emergence of later-life Neuropsychiatric Symptoms (NPS) as an at-risk state for cognitive decline and dementia and as a potential manifestation of prodromal dementia. How NPS mechanistically link to the development of Mild Cognitive Impairment (MCI) and Alzheimers disease (AD) is not fully understood. Potential mechanisms include either shared risk factors that are related to both NPS and cognitive impairment, or AD pathology promoting NPS. This is the first study to examine whether AD genetic loci, individually and as a genetic risk score, are a shared risk factor with MBI. 1377 older adults (aged 72-79; 738 males; 763 normal cognition) from the PATH Through Life project. MBI was assessed in accordance with Criterion 1 of the ISTAART-AA diagnostic criteria using the Neuropsychiatric Inventory. 25 LOAD risk loci were genotyped and a weighted genetic risk score (GRS) was constructed. Binomial logistic regression adjusting for age, gender, and education examined the association between LOAD GRS and MBI domains. An increase in the LOAD GRS and APOE*{varepsilon}4 were associated with higher likelihood of Affective Dysregulation; MS4A4A-rs4938933*C and MS4A6A-rs610932*G were associated with a reduced likelihood of Affective Dysregulation; ZCWPW1-rs1476679*C was associated with a reduced likelihood of Social Inappropriateness and Abnormal Perception; BIN1-rs744373*G and EPHA1-rs11767557*C were associated with higher likelihood of Abnormal Perception; NME8-rs2718058*G was associated with a reduced likelihood Decreased Motivation. These findings suggest a common genetic etiology between MBI and traditionally recognized memory problems observed in AD and improve our understanding of the pathophysiological features underlying MBI.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 67
- FWCI
- 4.30
- Field percentile
- top 5%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Polygenic Risk Scores for Alzheimer's Disease and Mild Cognitive Impairment in Hispanics/Latinos in the U.S: The Study of Latinos - Investigation ofNeurocognitive Aging
Tamar Sofer, Nuzulul Kurniansyah, … Myriam Fornage·medRxiv·Jan 8, 2021
- Late Onset Alzheimer’s disease risk variants in cognitive decline: The PATH Through Life Study
Shea J Andrews, Debjani Das, … Simon Easteal·bioRxiv·Aug 4, 2016
- ANU-ADRI and not Genetic Risk score predicts MCI in a cohort of older adults followed for 12 years
Shea Andrews, Ranmalee Eramudugolla, … Kaarin J Anstey·Alzheimer's Research & TherapyPeer-reviewed·Mar 4, 2017
- Polygenic effects on the risk of Alzheimer's disease in the Japanese population
Masataka Kikuchi, Akinori Miyashita, … Gary R. Conrad·Alzheimer s Research & TherapyPeer-reviewed·Feb 27, 2024
- Genetic drivers of progression in Alzheimers disease are distinct from disease risk
Celeste E. Cohen, Shane Fernandez, … Maryam Shoai·Alzheimer s Research & TherapyPeer-reviewed·Apr 25, 2026
- Population-specific polygenic risk for Alzheimer's disease is associated with Mini-Mental State Examination-based cognitive decline in a Japanese cohort
Yutaro Yanagida, Yutaka Nakachi, … Kazuya Iwamoto·medRxiv·Mar 28, 2026